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Neuroimmune-vascular cells and their pathological
disorders
Kirk J. Mantione
The initiation and persistence of multiple organ pathologies, which may
occur during life, are intimately associated with acute and chronic
dysregulatory metabolic processes. Multiple organ pathologies may also
be functionally associated with initiating traumatic events leading to
a chronic state of proinflammatory cellular insults with resultant prolonged
debilitation and negative quality of life. Along these lines, a large body of
preclinical and clinical literature has established that acute and chronic
perturbations of the functional coupling of vascular endothelial, immune,
and neural cell types represent major contributory factors to the initiation
and persistence of pathological states [1]. Furthermore, metabolic rundown
in each of these cell types is intimately linked to primary functional deficits
in their endosymbiont mitochondria. Mechanistically, dysregulation of
mitochondrial respiration leads to impairment of intermediary energy
metabolism, ATP production, and insufficient buffering of harmful reactive
oxygen species [2]. Resultant damage to mtDNA has profound effects on
mitochondrial rescue and biogenesis upon physiological demand. Similar
criteria may relate to the elucidation of key cellular mechanisms underlying
normal and premature ageing. In light of the above, common regulatory
events and their potential dysregulation in neuroimmune-vascular
disorders are listed below.
Endothelia serve as major cellular conduits mediating oxygen and
carbon dioxide exchange, nutrient transport, and autonomic tone in the
peripheral and CNS vasculature. Notably, functional deficiencies in vascular
endothelia has been documented in variety of human metabolic disorders
including diabetes and cardiovascular disease [3-19]. Mitochondria-
associated oxidative stress has been proposed as a major contributing
factor to the severity of endothelial malfunction in these same metabolic
disorders [3-19].
The immune system serves to defend the body from external and
internal threats and keep multiple organ systems in metabolic homeostasis.
Ongoing host-defense mechanisms utilize complementary regulatory
processes to perform existential functions ranging from antibody
production to immune surveillance and phagocytosis. Functional
immunodeficiencies including perturbations in neuroimmune and vascular
endothelial cellular coupling has been observed in multiple human
pathological disorders [1, 20-34]. It has also become apparent that
dysregulation of mitochondrial function mediated by disruption of
constitutive nitric oxide signaling mechanisms represents a strong
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contributing  factor  in  neuroimmune/vascular
endothelial-coupled cellular pathologies [1, 20-34].
The  nervous  system  serves  an  existential
integrative capacity for functional entrainment of
multiple organ function. Within the central and
peripheral nervous systems, sensory, motor, and
intrinsic neurons employ a wide variety of chemical
and gaseous messenger molecules. Accordingly,
central and peripheral neurons integrate sensory
input  and  coordinated  motor  responses  via
immediate and long lasting chemical messengers.
As  stated  above,  vital  neuroimmune/vascular
endothelial-coupled metabolic regulation modu  -
lates homeostasis of cellular energy production in
multiple  organ  systems.  Its  dysregulation  is
intimately associated with a variety of acute and
chronic pathophysiological disorders [35-55].
Multiple  organ  pathologies  are  intimately
associated with acute and chronic dysregulation
of metabolic processes responsible for normal
neuroimmune/vascular  endothelial  coupling
events. An in depth analysis of perturbation of
common regulatory events underlying normal
mitochondrial function will elucidate convergent
mechanisms  leading  to  the  initiation  and
persistence  of  multiple  organ  pathologies  in
human metabolic disorders. 
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